Dermata Therapeutics, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: DRMA
Dermata Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker DRMA. It has reported private securities offerings to the US SEC, most recently $4.1 million sold in a notice filed in 2026.
What does Dermata Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $4.1 million sold (2026).
Frequently asked questions about Dermata Therapeutics
Where is Dermata Therapeutics headquartered?
Dermata Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Dermata Therapeutics do?
Dermata Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Dermata Therapeutics a public company?
Yes. Dermata Therapeutics, Inc. trades on Nasdaq under the ticker DRMA.
When was Dermata Therapeutics founded?
The earliest incorporation on record for Dermata Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.